Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial
Margaret M. Redfield, Horng H. Chen, Barry A. Borlaug, Marc J. Semigran, Kerry L. Lee, Gregory Lewis, Martin M. LeWinter, Jean L. Rouleau, David A. Bull, Douglas L. Mann, Anita Deswal, Lynne W. Stevenson, Michael M. Givertz Elizabeth O Ofili, Christopher M. O'Connor, G. Michael Felker, Steven R. Goldsmith, Bradley A. Bart, Steven E. McNulty, Jenny C. Ibarra, Grace LinJae K. Oh, Manesh R. Patel, Raymond J. Kim, Russell P. Tracy, Eric J. Velazquez, Kevin J. Anstrom, Adrian F. Hernandez, Alice M. Mascette, Eugene Braunwald
Dive into the research topics of 'Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial'. Together they form a unique fingerprint.